FCH
SANA icon

Freestone Capital Holdings’s Sana Biotechnology SANA Stock Holding History

Freestone Capital Holdings’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.1K Hold
15,300
– – ﹤0.01% 567
2025
Q4 		$62.3K Buy
+15,300
New +$68.5K ﹤0.01% 545

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Freestone Capital Holdings's SANA Position: Q1 2026 in Review

Freestone Capital Holdings held its Sana Biotechnology (SANA) position steady in Q1 2026 at 15,300 shares worth $44.1K. The position accounts for ﹤0.01% of the portfolio, ranked #567.

Freestone Capital Holdings first reported a position in SANA in Q4 2025 and has held it in 2 quarters since. The position peaked at $62.3K in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Freestone Capital Holdings held 15,300 shares of Sana Biotechnology worth $44.1K as of Q1 2026.
  • Freestone Capital Holdings left its Sana Biotechnology share count unchanged in Q1 2026.
  • Sana Biotechnology made up ﹤0.01% of Freestone Capital Holdings's portfolio in Q1 2026, its #567 holding.
  • Freestone Capital Holdings first reported a position in Sana Biotechnology in Q4 2025 and has held it in 2 quarters since.
  • Freestone Capital Holdings's Sana Biotechnology position peaked at $62.3K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Freestone Capital Holdings's 13F filing for Q1 2026, filed 13 May 2026.